Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 482481 - 482500 out of 495964 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FB01) inotuzumab ozogamicin | BESPONSA 0.9MG/VIL INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | Pfizer,Inc. |
| USA | (L01FB01) inotuzumab ozogamicin | BESPONSA 0.9MG/VIL INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | Pfizer,Inc. |
| USA | (L01FC01) daratumumab | DARZALEX 100MG/5ML INJ SOLN | 1X5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 100MG/5ML INJ SOLN | 1X5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX FASPRO 120MG/2000UNIT INJ SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX FASPRO 120MG/2000UNIT INJ SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC02) isatuximab | SARCLISA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FC02) isatuximab | SARCLISA | 25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FC02) isatuximab | SARCLISA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FC02) isatuximab | SARCLISA | 25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FD01) trastuzumab | HERCEPTIN HYLECTA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERCEPTIN HYLECTA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERCEPTIN 150MG SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERCEPTIN 150MG SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | KANJINTI 150MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab | KANJINTI 150MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 150MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 150MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
Pages
